|Articles|March 1, 2015
- BioPharm International-03-01-2015
- Volume 28
- Issue 3
BioPharm International, March 2015 Issue (PDF)
Click the title above to open the BioPharm International March 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 11 years ago
USP Publishes Monoclonal Antibody Guidelinesalmost 11 years ago
Maintaining the Stability of Biologicsalmost 11 years ago
Springing Forwardalmost 11 years ago
Reinventing the Cold Chain in a High-Stakes Marketalmost 11 years ago
A Robust CAPA System for a Global Supply Chainalmost 11 years ago
CMOs Plan for Capacity Expansionsalmost 11 years ago
Vaccine Development and Production Challenges Manufacturersalmost 11 years ago
Detecting Protein Aggregates and Evaluating their Immunogenicityalmost 11 years ago
Re-use of Protein A Resin: Fouling and Economicsalmost 11 years ago
SEC in the Modern Downstream Purification ProcessNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5
